Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials.
Nutr RevSep 6, 2026
Zizheng Nie, Yingying Liu, Mu Zhang et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis of 34 randomized controlled trials evaluated the effects of oral taurine supplementation on cardiometabolic risk factors in adults. The study found significant reductions in fasting blood glucose by 5.90 mg/dL and glycated hemoglobin A1c by 0.21%, among other improvements, suggesting taurine may effectively reduce cardiometabolic disease risk.
Key findings
- Fasting blood glucose decreased by 5.90 mg/dL with taurine supplementation.
- Glycated hemoglobin A1c levels reduced by 0.21%.
- Triglycerides decreased by 14.42 mg/dL.
- Systolic blood pressure reduced by 4.38 mmHg.
Why it matters
Understanding the impact of taurine on cardiometabolic risk factors is crucial for clinicians, as it may offer a dietary intervention to mitigate the risk of cardiometabolic diseases, which are prevalent and associated with significant morbidity and mortality.